/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for A.P. Pharma Inc.\n \n\n\n\n\n
Nov 22 11:21 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 16, 2009 6:00 AM EST
\n\n \n A.P. Pharma Reports Third Quarter 2009 Financial Results - Business Wire\n \n \n
\n\n Oct 28, 2009 6:00 AM EDT
\n\n \n A.P. Pharma to Transfer to Nasdaq Capital Market - Business Wire\n \n \n
\n\n Oct 20, 2009 6:00 AM EDT
\n\n \n A.P. Pharma Announces Private Equity Placement - Business Wire\n \n \n
\n\n Sep 21, 2009 6:00 AM EDT
\n\n \n A.P. Pharma Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule - Business Wire\n \n \n
\n\n Sep 15, 2009 6:05 AM EDT
\n\n \n A.P. Pharma and Merial Enter into Worldwide Agreement - Business Wire\n \n \n
\n\n Jul 12, 2007 7:30 AM EDT
\n\n \n Dawson James Securities Initiates Research Coverage on A.P. Pharma, Inc. (Nasdaq: APPA) with a Speculative Buy Rating - 12-18 Month Target Price $4.50 - PR Newswire\n \n \n
\n
\n\n");